Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Fingerprint Dive into the research topics where Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

    • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Profiles

    No photo of Alessandra Anna Affatato

    Alessandra Anna Affatato

    Person: Academic

    No photo of amelia altavilla

    amelia altavilla

    Person: Academic

    20192019
    No photo of Mattia Altini

    Mattia Altini

    Person: Academic

    20052020

    Projects

    Istituto Scientifico Romagnolo - APPROPRIATEZZA, ESITI, VALUE DEL FARMACO E MODELLI ORGANIZZATIVI FUNZIONALI ALLA CONTINUITAâ¿¿ DEI PERCORSI DIAGNOSTICO-TERAPEUTICI IN ONCOLOGIA

    Ricerca, U.

    1/1/19 → 12/31/19

    Project: Other project

    Istituto Scientifico Romagnolo - TERAPIE INNOVATIVE, TRIALS DI FASE I-III E DI STRATEGIA TERAPEUTICA BASATI SU MODELLI PRECLINICI, MECCANISMI ONCO-IMMUNOLOGICI, NANOVETTORI

    Ricerca, U.

    1/1/19 → 12/31/19

    Project: Other project

    Istituto Scientifico Romagnolo - Progetti Eranet e Ministero affari esteri e Progetti di rete

    Ricerca, U.

    1/1/19 → 12/31/19

    Project: Other project

    Research Output

    An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia

    Cerchione, C., Martinelli, G., Pedatella, S., De Nisco, M., Pugliese, N., Manfra, M., Marra, N., Ronconi, S., De Giorgi, U., Altini, M., Simonetti, G., Di Rorà, A. G. L., Bravaccini, S., Catalano, L., Dora Iula, V., Pagano, F., Picardi, M., Bolognese, A., Pane, F. & Martinelli, V., Jan 1 2020, In : Anti-Cancer Drugs. 31, 1, p. 67-72 6 p.

    Research output: Contribution to journal › Article

    • Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study

    Faloppi, L., Puzzoni, M., Casadei Gardini, A., Silvestris, N., Masi, G., Marisi, G., Vivaldi, C., Gadaleta, C. D., Ziranu, P., Bianconi, M., Loretelli, C., Demurtas, L., Lai, E., Giampieri, R., Galizia, E., Ulivi, P., Battelli, N., Falcone, A., Cascinu, S. & Scartozzi, M., Jan 1 2020, (Accepted/In press) In : Targeted Oncology.

    Research output: Contribution to journal › Article

    • Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study

    on behalf of the Italian Melanoma Intergroup (IMI), Jan 1 2020, (Accepted/In press) In : Journal of Geriatric Oncology.

    Research output: Contribution to journal › Article